Ramizol

has antimicrobial activity; structure in first source

Also Known As:

1,3,5-tris((1E)-2'-(4''-benzoic acid)vinyl)benzene; 1,3,5-tris(2'-(4'-benzoic acid)vinyl)benzene; 4,4',4''-(1,3,5-benzenetriyltri-(1e)-2,1-ethenediyl)tris(benzoic acid)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Benzoates: 426
        Ramizol: 2
        Benzylidene Compounds: 10
        Stilbenes: 657
        Ramizol: 2
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Benzoates: 426
      - Ramizol: 2

Experts

1.	Boulos, Ramiz A: 2 articles (01/2019 - 12/2016)
2.	Chen, Jayson: 1 article (01/2019)
3.	Kimzey, Amy: 1 article (01/2019)
4.	Koetzner, Lee: 1 article (01/2019)
5.	Lansita, Janice: 1 article (01/2019)
6.	Mendes, Odete: 1 article (01/2019)
7.	Sibley, Katherine: 1 article (01/2019)
8.	Miesel, Lynn: 1 article (12/2016)
9.	Prestidge, Clive A: 1 article (12/2016)
10.	Rao, Shasha: 1 article (12/2016)

Related Diseases

1.	Colitis 12/01/2016 - "Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis."
2.	Clostridium Infections 01/01/2019 - "Ramizol, a first-in-class styrylbenzene based antibiotic, is an investigational drug indicated for Clostridium difficile infections (CDI). "
3.	Body Weight (Weight, Body) 01/01/2019 - "Additionally, there were no changes in mean body weight, body weight gain, food consumption or food efficiency for male and female rats attributable to Ramizol administration. "

Related Drugs and Biologics

1.	Anti-Bacterial Agents (Antibiotics)
2.	Investigational Drugs